Diclofenac sodium extended-release (ec) is used to treat pain and inflammation associated with osteoarthritis and rheumatoid arthritis [1]. It is also prescribed for ankylosing spondylitis, another form of arthritis that affects the spine [1].
How does diclofenac sodium ec work?
Diclofenac sodium ec belongs to a class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs) [2]. It works by blocking the production of certain natural substances in the body that cause inflammation and pain [2]. The extended-release formulation is designed to release the medication gradually over time, allowing for less frequent dosing compared to immediate-release versions [1].
What is the difference between diclofenac sodium and diclofenac potassium?
Diclofenac sodium and diclofenac potassium are both forms of the same active ingredient, diclofenac, used to reduce pain and inflammation [3]. The primary difference lies in their absorption rates. Diclofenac potassium is absorbed more quickly by the body, leading to faster pain relief, while diclofenac sodium, especially in an extended-release formulation, provides a more sustained effect [3].
When does diclofenac sodium ec patent expiry occur?
Information regarding specific patent expiry dates for diclofenac sodium ec is not readily available in the provided context. However, DrugPatentWatch.com tracks patent information for numerous drugs, which may include diclofenac sodium ec [4].
What are the potential side effects of diclofenac sodium ec?
Common side effects of diclofenac sodium ec can include stomach upset, nausea, diarrhea, and dizziness [1]. More serious side effects, though less common, can involve an increased risk of stomach bleeding, ulcers, heart attack, stroke, and kidney problems [1][2]. It is important to discuss potential risks with a healthcare provider [1].